Acquisition by Kupiec James William of 1500 shares of Cassava Sciences at 22.0 subject to Rule 16b-3

SAVA Stock  USD 26.48  5.70  17.71%   
About 61% of all Cassava Sciences' investors are looking to take a long position. The analysis of overall sentiment of trading Cassava Sciences stock suggests that some investors are interested at this time. The current market sentiment, together with Cassava Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Cassava Sciences stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Cassava Sciences Officer: Chief Medical Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 1500 common stock at 22.0 of Cassava Sciences by Kupiec James William on 22nd of April 2024. This event was filed by Cassava Sciences with SEC on 2024-04-18. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cassava Sciences' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cassava Sciences' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cassava Sciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cassava Sciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cassava Sciences Historical Investor Sentiment

Investor biases related to Cassava Sciences' public news can be used to forecast risks associated with an investment in Cassava. The trend in average sentiment can be used to explain how an investor holding Cassava can time the market purely based on public headlines and social activities around Cassava Sciences. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Cassava Sciences' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Cassava Sciences and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Cassava Sciences news discussions. The higher the estimate score, the more favorable the investor's outlook on Cassava Sciences.

Cassava Sciences Fundamental Analysis

We analyze Cassava Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cassava Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cassava Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Cassava Sciences is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Cassava Sciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cassava Sciences stock to make a market-neutral strategy. Peer analysis of Cassava Sciences could also be used in its relative valuation, which is a method of valuing Cassava Sciences by comparing valuation metrics with similar companies.

Peers

Cassava Sciences Related Equities

MDGLMadrigal Pharmaceuticals   5.53   
0%
52.0%
MCRBSeres Therapeutics   5.48   
0%
52.0%
KRYSKrystal Biotech   4.45   
0%
42.0%
CVACCureVac NV   3.91   
0%
37.0%
VIRVir Biotechnology   2.45   
0%
23.0%
INMBINmune Bio   2.31   
0%
21.0%
EXELExelixis   2.24   
0%
21.0%
VKTXViking Therapeutics   1.86   
0%
17.0%
TGTXTG Therapeutics   1.51   
0%
14.0%
AVXLAnavex Life   1.00   
0%
9.0%
AXSMAxsome Therapeutics   0.50   
0%
4.0%
BIVIBiovie   1.93   
18.0%
0%
ANVSAnnovis Bio   2.06   
19.0%
0%
CGTXCognition Therapeutics   2.27   
21.0%
0%
RVPHReviva Pharmaceuticals   8.06   
76.0%
0%
BTAIBioXcel Therapeutics   10.53   
100.0%
0%

Complementary Tools for Cassava Stock analysis

When running Cassava Sciences' price analysis, check to measure Cassava Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cassava Sciences is operating at the current time. Most of Cassava Sciences' value examination focuses on studying past and present price action to predict the probability of Cassava Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cassava Sciences' price. Additionally, you may evaluate how the addition of Cassava Sciences to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities